Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

Bulgaria-fouded software developer Lab Thread said on Monday that it launched the Beta version of its genetic and research laboratories management platform, six months after securing an investment of ...

A wireless, flexible, micro-LED array delivers patterned optogenetic stimulation through the skull to generate artificial perception in mice.

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of ...

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Paranovus Entertainment (NASDAQ: PAVS) Goes Parabolic on Interim Results ...

North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...

Cell death triggered by GPX4 loss was slowed in cell cultures and in mouse model using compounds that specifically inhibit ferroptosis.